Background illustration for clinical trials search

Paid Clinical Trials Fort Smith

Discover 128 paid clinical trials in Fort Smith, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 128

Protein and Exercise for Postmenopausal Women's Wellbeing

for

Postmenopausal

Location: Fayetteville AR

Sponsor: University of Arkansas, Fayetteville

Sex: Female

Age: 0+

Code: NCT06849817

Recruiting

Dental-Child Interaction Training

for

Behavior and Behavior Mechanisms, Child Behavior

Location: Fayetteville AR, Gainesville FL

Sponsor: University of Florida

Sex: All

Age: 18 - 70+

Code: NCT06138405

Recruiting

GAINS Expert Guiding Technology to Coach Life Skill Teaching

for

GAINS Expert Guiding Technology to Coach Life Skill Teaching

Location: Fayetteville AR

Sponsor: Guiding Technologies Corporation

Sex: All

Age: 3 - 10

Code: NCT07203105

Recruiting

Time Restricted Feeding, Muscle, and Metabolism

for

Overweight, Obesity

Location: Fayetteville AR

Sponsor: University of Arkansas, Fayetteville

Sex: All

Age: 25 - 50

Code: NCT04949451

Recruiting

New

Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study

for

Decision-Making, Patient Care, Treatment Decisions

Location: Fayetteville AR, Albuquerque NM, Roanoke VA

Sponsor: University of Arkansas, Fayetteville

Sex: All

Age: 18+

Code: NCT07842367

Phase2, Recruiting

Combining a Smartphone App With Medications to Manage Heavy Drinking

for

Alcohol Use Disorder (AUD)

Location: Fayetteville AR, Dallas TX, Omaha NE, Nashville TN,

Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT06303778

Recruiting

A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue

for

Breast Cancer Screening

Location: Fayetteville AR

Sponsor: Namida Lab

Sex: Female

Age: 18 - 70+

Code: NCT05268224

Recruiting

Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

for

Aortic Aneurysm, Abdominal

Location: Washington AR, Columbia MO, St Louis MO, Maywood IL,

Sponsor: Rijnstate Hospital

Sex: All

Age: 18+

Code: NCT05484115

Recruiting

New

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

for

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma,

Location: Fayetteville AR, Springdale AR, Rogers AR,

Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07504588

Phase2, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for

Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,

Location: Fayetteville AR, Springdale AR, Rogers AR, Paris TX,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase3, Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for

Metastatic Castration-Resistant Prostate Cancer

Location: Fayetteville AR, Springdale AR, Rogers AR,

Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase3, Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for

Oligometastatic Prostate Cancer (OMPC)

Location: Fayetteville AR, Dallas TX, Kansas City KS, St Louis MO,

Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase3, Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

for

Non-Muscle Invasive Bladder Urothelial Carcinoma,

Location: Fayetteville AR, Springdale AR, Rogers AR,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06770582

Phase2, Recruiting

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

for

Advanced Clear Cell Renal Cell Carcinoma,

Location: Fayetteville AR, Springdale AR, Rogers AR, Jonesboro AR,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07383441

Phase3, Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for

Urothelial Cancer, Advanced/Metastatic Urothelial Cancer,

Location: Fayetteville AR, Springdale AR, Rogers AR, Irving TX,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07421700

Phase1, Phase2, Recruiting

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

for

Locally Advanced Pancreatic Adenocarcinoma,

Location: Fayetteville AR, Springdale AR, Rogers AR, Jonesboro AR,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06998940

Phase3, Recruiting

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

for

Small Cell Lung Cancer (SCLC)

Location: Fayetteville AR, Springdale AR, Rogers AR, Paris TX,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07226999

Phase2, Phase3, Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for

Locally Advanced Cervical Adenocarcinoma,

Location: Fayetteville AR, Springdale AR, Rogers AR, Tulsa OK,

Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase3, Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for

Metastatic Castration Sensitive Prostate Cancer (mCSPC),

Location: Fayetteville AR, Springdale AR, Rogers AR,

Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT07028853

Phase3, Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

for

Muscle Invasive Bladder Urothelial Carcinoma,

Location: Fayetteville AR, Springdale AR, Rogers AR,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061964

Phase2, Recruiting

Paid Clinical Trials Fort Smith

Filter results

Protein and Exercise for Postmenopausal Women's Wellbeing

Dental-Child Interaction Training

GAINS Expert Guiding Technology to Coach Life Skill Teaching

Time Restricted Feeding, Muscle, and Metabolism

Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study

Interested in new trials?

Combining a Smartphone App With Medications to Manage Heavy Drinking

A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue

Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial